Usage patterns of transdermal nicotine when purchased as a non-prescription medicine from pharmacies

Tobacco Control

Volumn 7, Issue 2, 1998, Pages 161-167

  Shaw, John P ^a   Ferry, Donald G ^a   Pethica, Damian ^b,c   Brenner, Daniel ^d,e   Tucker, Ian G ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b Ciba Geigy (NZ) Ltd   (New Zealand)

^c Diversity New Zealand Ltd   (New Zealand)

^d CIBA GEIGY LTD   (Switzerland)

^e FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

Author keywords

Nicotine replacement therapy; Nicotine skin patch; Over the counter medication; Transdermal nicotine

Indexed keywords

NON PRESCRIPTION DRUG;

ADULT; ARTICLE; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; NEW ZEALAND; PHARMACY; PLANT; QUESTIONNAIRE; TOBACCO; TOBACCO DEPENDENCE;

ADMINISTRATION, CUTANEOUS; ADULT; DRUGS, NON-PRESCRIPTION; FEMALE; HUMANS; MALE; NEW ZEALAND; PHARMACY; PLANTS, TOXIC; QUESTIONNAIRES; TOBACCO; TOBACCO USE DISORDER;

EID: 0032082371     PISSN: 09644563     EISSN: None     Source Type: Journal    
DOI: 10.1136/tc.7.2.161     Document Type: Article

References (15)

1. Palmer KJ, Buckley MM, Faulds, D. Transdermal nicotine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs 1992;44:498-529.
2. Benowitz NL. Nicotine replacement therapy: what has been accomplished - can we do better? Drugs 1993;45:157-70.
3. Fiore MC, Jorenby DE, Baker TB, et al. Tobacco dependence and the nicotine patch: clinical guidelines for effective use. JAMA 1992;268:2687-94.
4. Fiore MC, Bailey WC, Cohen SJ, et al. Smoking cessation. Clinical Practice Guideline No 18. Rockville, Maryland: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, April 1996. (AHCPR Publication No 96-0692.)
5. Silagy C, Mant D, Fowler G, et al. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994;343:139-42.
6. Fiore MC, Stevens SS, Jorenby DE, et al. The effectiveness of the nicotine patch in smoking cessation: a meta-analysis. JAMA 1994;271:1940-7.
7. Cepada-Benito A. A meta-analytical review of the efficacy of nicotine chewing gum. J Consult Clin Psychol 1993;61:822-30.
8. Tonnesen P, Norregaard J, Mikkelsen K, et al. A double blind trial of a nicotine inhaler for smoking cessation. JAMA 1993;269:1268-71.
9. Sutherland G, Stapleton JA, Russell MA, et al. Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 1992;340:324-9.
10. Hjalmarson A, Franzon M, Westin A, et al. Effect of nicotine nasal spay on smoking cessation. A randomized, placebo-controlled, double-blind study. Arch Int Med 1994;154:2567-72.
11. Drug Abuse Advisory Committee, Food and Drug Administration. Nicotine substitution products. Rockville, Maryland: US Food and Drug Administration, 1992.
12. McNagny SE, Ahluwalia JS. Use of over-the-counter nicotine patch for smoking cessation: prudent or premature? (Letter.) JAMA 1996;276:371.
13. Anon. New nicotine patch helps smokers quit. NZ Pharm 1990;10:28.
14. Anon. Nicotinell TTS product insert. Auckland, New Zealand: Ciba-Geigy (NZ), 1991.
15. Orleans CT, Resch N, Noll E, et al. Use of transdermal nicotine in a state-level prescription plan for the elderly: a first look at 'real-world' patch users. JAMA 1994;271:601-7.